ACSL4 and neoplasm: The tumor growth rate of MCF-7 Tet-Off/ACSL4 tumor xenografts between days 45 and 70 was significantly higher than that in doxycycline-treated animals (Figure 2B) and than that in animals inoculated by inoculation with MCF-7 Tet-Off empty vector cells.